|
|
|
Accommodations -- Room Block extended until Wednesday, Sept. 19
| |
 26 N Royal Street
Mobile, AL 36602 |
|
APPA has reserved a block or rooms at the Battle House Renaissance Mobile Hotel & Spa. The conference rate is $159 per night. Make your hotel reservations by calling (866) 316-5-957 and asking for the Alabama Psychiatric Physicians Association room block. Make a room reservation online. Don't miss out on this great rate!
Reserve your room today!
| |
Call for Abstracts - Deadline is Sept. 21
In conjunction with the Fall Conference, APPA will host a Resident/Medical Student Poster Contest. Residents and students who are interested in participating are asked to coordinate with a faculty member in preparing a poster for the meeting. The posters are assigned abstract numbers and are published on the APPA website so count as “Published Abstracts” on your CV. This is a very easy way to build your academic portfolio!
| |
| Conference Spotlight: Evaluating and Treating Athletes with Mental Health and Substance Use Disorders
Stephen M. Taylor, MD, MPH, FASAM
| |
Stephen Taylor, MD, MPH, is a certified medical review officer and serves on the board of directors of the Medical Review Officer Certification Council (MROCC) of Pathway Healthcare, LLC. Currently, he is completing his tenth year as the medical director of the Player Assistance/Anti-Drug Program of the National Basketball Association (NBA) and the National Basketball Players Association (NBPA), a program Dr. Taylor designed and implemented.
His greatest passion has been providing education and specialized care to adolescent and young adult patients and their families afflicted with drug and alcohol addictions and general psychiatric disorders.
Dr. Taylor earned his medical degree from the Howard University College of
Medicine, and then earned a master’s degree in public health from the Harvard
School of Public Health.
He is a Fellow of the American Society of Addiction Medicine (ASAM), and a member of the American Academy of Addiction Psychiatry, the American Academy of Child and Adolescent
Psychiatry, and the International Society of Sport Psychiatry.
Dr. Taylor will present Evaluating and Treating Athletes with Mental Health and Substance Use Disorders on Saturday, Oct. 27, at 11:15 a.m.
| |
Laura Baird, LPC, Montgomery Psychiatry Associates
Richard E. Blackwell, PhD, MD, University of Alabama - Birmingham
Judith Bowen, MD, DFAPA, Drs. Bowen & Kowalski LLP, Birmingham
Garrett Dunn, UABSOM - Huntsville
Mark Erickson, MD, Anchorage, AK
Edgar W. Finn, MD, AltaPointe Health Systems, Talladega
Zaunklay Finnila, MD, UAB Family Medicine, Huntsville
S. Nassir Ghaemi, MD, MPH, Tufts University, Cambridge, MA
Griffin Gibson, MD, USA/AltaPointe, Mobile
Leona J. Graham, MD, FAPA, Central Alabama Veterans Health Care System, Tuskegee
James A. Jeffery, MD, Mental Health Center of North Central Alabama, Decatur
Samuel Johnston, University of Alabama School of Medicine, Birmingham
Stephen Kowalski, MD, DFAPA, Drs. Bowen & Kowalski LLP, Birmingham
John R. Langlow, MD, New Directions, Alabaster
Clinton Martin, MD, FAPA, University of Alabama - Birmingham
Janaki Nimmagadda, MD, FAPA, Ireland Center - Childrens Behavioral Health, Birmingham
Abhilasha Pandey, MD, Charles T. Nevels, MD, PC, Tuscaloosa
Steven Shows, JD, ProAssurance, Birmingham
Nathan Smith, MD, UAB Health Service Foundation, Birmingham
Terri Steele, MD, Eastside Mental Health Center, Birmingham
Lindsey Stewart, MD, USA Health System, Mobile
Patrick Tapia, MD, Affiliated Mental Health Services, Inc., Birmingham
Stephen M. Taylor, MD, MPH, FASAM, Pathway Healthcare, LLC, Birmingham
Tarak Vasavada, MD, DFAPA, UAB - Huntsville
Harold Veits, MD, DLFAPA, Private Practice, Mobile
| |
APPA depends on support from vendors to make our conference affordable for attendees. Please share our prospectus with companies who visit your facility and invite them to be an exhibitor. Contact Meghan Martin for details. APPA thanks the following companies for their support of our Spring 2018 Conference! Acadia Pharmaceuticals, Inc.
Alfasigma USA, Inc.
Alkermes, Inc.
Allergan
AltaPointe Health Systems
Brainsway USA
Blue Cross Blue Shield of Alabama.
Janssen Pharmaceuticals, Inc.
Lundbeck
Neurocrine Biosciences, Inc.
ProAssurance, Inc.
Professional Risk Management Services, Inc.
Sunovion Pharmaceuticals, Inc.
Team Health
TEVA Pharmaceuticals
Wexford Health Sources, Inc.
| |
- Acquire a widening of conceptual and diagnostic framework, and become aware of the insufficiencies of current diagnostic concepts and processes.
- Name endocrinological factors and safe treatments in psychiatric patients with hormonal abnormalities.
- Recognize the dilemma involved in performance enhancing drugs, addiction risks, and needed treatments in high school and college athletes.
- Identify findings about intra-familiar suppression or enhancement of sexual attraction, and apply the Westermarck effect and related findings to a clinical population.
- Describe prime risk scenarios, safe diagnostics, treatment and documentation strategies, and ways to provide safety to patients, coworkers and physicians.
| |
The Alabama Psychiatric Physicians Association 2018 Fall Conference offers attendees 7.5 hours of instruction.
| |
|
|
|
|
